Brokenlinein C indicatesline ofequivalence. B.J.is a caseof hyperthyroidism.
FIlled symbol indicates the sole case found to have antibodies against the radioligand used in the Amer$ex-M procedure tered in several cases, which we re-assayed after a polyethylene glycol (PEG) precipitation step suggested by the manufacturer for eliminating antibody-related interference. Figure IA free-T4 values, is one of the three thyrotoxic patients needing therapy that we identified among the 2000 patients. Possibly, some of the falsely increased values by the Ainerlite procedure were caused by anti-ligand antibodies. All non-thyroxin-treated patients with free T4 >23.0 pmol/L had been tested for antibodies against the radiolabeled T4 analog; one patient so affected was identified, and this patient had abnormally high free-T4 values with both methods (ifiled symbol in Figure lB and C) . Clinical and other laboratory information in this case indicates absence of thyroid dysfunction. The finding of artifactually low free-T4 values by the luminometric free-T4 assay was unexpected, and the cause(s) is (are) so far unknown. Furthermore, we do not know whether the interferences leading to falsely.. high or falsely-low luminometric free-T4 values are specific for the Amerlite system or common for all similar enzyme immunoassays. 
Increased Fibrinogen Concentration as Determined

F.R.G.) according to the manufacturer's instruction, with
two exceptions: sample dilution (100-fold -* 10-fold) and sample volume (0.02 mL -0.003 mL). Thrombin dissolved in buffer (Tris HC1, heparmn,aprotinin, NaCl) was used as reagent 1, and Chromozym TH (Tos-Gly-Pro-Arg-p-nitroaniide) as reagent 2. Citrated plasma, the sample recommended by both Hoechst and Boehringer Mannheim, was used as a sample in both analyses, but diluted 10-fold with isotonic saline.
When fibrinogen and antithrombin ifi were measured simultaneously in a diluted plasma sample, the fibrinogen concentration was seen to be increased compared with that obtained by separate analysis:
Flbdnogen concn, g/L To confirm this phenomenon, we mixed the above four reagents in a test tube, but observed the development of greenish color 405 urn) only in the mixture of NAntiserum and Chromozym TH. The absorption spectrum of this color overlapped immunoturbidity at 340 urn, indicating the increase in fibrinogen concentration. We added 2-mercaptoethanol or sodium azide to Chromozym TH, because N-Antiserum contained both substances, but no color developed.
The reason for this phenomenon is unclear, but we obtained the correct fibrinogen concentration by performing a dummy analysis after the antithrombin ifi determination. In the dummy analysis we used "Extran" (a detergent applied in the Hitachi 705; Merck) as the reagent. We suspect that small amounts of Chromozym TI! sticking to the reagent pipette were dispersed in the simultaneous fibrinogen analysis. Clearly, cyclosporine is toxic for the endocrine pancreas (1) (2) (3) (4) (5) (6) (7) . It can also induce asymptomatic hyperamylasemia in renal-transplant patients (8). Does the same alteration appear in cyclosporine-treated rats?
In 10 male Wistar control rats, serum lipase activity as determined with the Boehringer-Mannheim UV-system kit was not detectable (<12 U/L; reference values in man <190 UIL). Amylasemia (as measured with the bioM#{233}rieux kit), mean 1940, SD 30 UIL, was 30-to 40-fold that observed in the human (<53 U/L). In the latter, salivary-and pancreatic-type arnylase activities are observed together in serum after electrophoretic separation (Analis, Belgium); in the rat, only salivary-type amylase was present. The wheatderived inhibitor protein (Pharmacia kit), which inhibits -85% of the human salivary amylase activity, had no action on rat salivary amylase. Pancreatic-type amylase in tissue from both rat and human was inhibited by -35-40% by this inhibitor protein. In 10 rats intoxicated with cyclosporine (oral administration of 50 mg/kg body weight during eight days), activities of lipase and pancreatic-type amylase in serum remained undetectable. In addition, light and electron microscopy showed no major alteration in the exocrine pancreas, whereas the already described (1) morphologic changes of pancreatic B cells were present.
Evidently cyclosporine induces neither changes in serum pancreatic-enzyme in serum nor in morphology of the exocrine pancreas in the rat.
